cemiplimab

Who we are

• April 5, 2022

  REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors

• January 1, 1970

  A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations